Slide CordenPharma scientist in lab coat holding binder for News & Press header with white global connectivity background

NEWS & PRESS


News

September 20, 2021

CordenPharma COVID-19 Customer Letter

September, 20 2021
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.
June 29, 2021

CordenPharma 15 Year Anniversary

June 28, 2021
CordenPharma 15 Year Anniversary > Videos that highlight our integrated facility network
June 23, 2021

CEO Michael Quirmbach Talks New Funding & Importance of CDMO End-to-End Services

June 23, 2021
Global Business Reports Interview: CEO Michael Quirmbach Talks Funding & CDMO End-to-End Services
April 28, 2021

When the EU’s Covid-19 Vaccine Drive Stumbled, It Turned to Mr. Fixit

April 28, 2021
> Wall Street Journal: When the EU’s Covid-19 Vaccine Drive Stumbled, It Turned to Mr. Fixit
April 21, 2021

Vaccine: Dr. Clemens Horn, The Magician Chemist of CordenPharma

April 21, 2021
Vaccine: Dr. Clemens Horn, The Magician Chemist of CordenPharma
April 19, 2021

Revolo Bio & CordenPharma Sign Manufacturing Agreement for Peptide API Supply

April 19, 2021
News > Revolo Bio & CordenPharma Sign MSA for the Supply of Peptides APIs for ‘1104 Clinical Trials
April 5, 2021

EU Commissioner Thierry Breton Visits CordenPharma Chenôve on April 4, 2021

April 5, 2021
EU Commissioner Thierry Breton visits CordenPharma Chenôve on Easter.
March 24, 2021

Nanos & CordenPharma Sign New Collaboration Agreement

March 24, 2021
News > CordenPharma and Nanos of South Korea sign a new collaboration agreement relating to the production of Peptides.
January 22, 2021

CEO Magazine Interviews CordenPharma CEO & President Michael Quirmbach

Jan 22, 2021
CEO Magazine Interviews CordenPharma CEO & President Michael Quirmbach
December 8, 2020

Eiger BioPharmaceuticals: FDA Approval of Zokinvy™ (Ionafarnib)

December 8, 2020
News > CordenPharma congratulates Eiger BioPharmaceuticals on their recent FDA Approval of Zokinvy (lonafarnib).
November 16, 2020

Moderna Positive Phase 3 Results of mRNA-1273 Vaccine Candidate

November 16, 2020
News > CordenPharma Congratulates Moderna on positive Phase 3 results of mRNA-1273 COVID-19 vaccine.
October 23, 2020

Coronavirus Challenges & Opportunities

October 23, 2020
Article Interview > CHEManager Interviews Dr. Michael Quirmbach on the Coronavirus Opportunities for CDMOs
October 8, 2020

COVID-19 Affect on CDMO Pharma Services

October 8, 2020
Article Contribution > For Pharmaceutical services, it’s the best of times in the worst of times
October 7, 2020

Flexible Aseptic Filling Solutions Required

October 7, 2020
Article > Filling in: How Stevanato Group Supports Cordenpharma's Expansion
September 21, 2020

Webinar – Your Injectable Roadmap for Combination Products

September 21, 2020
Webinar On Demand > Your Injectable Roadmap for Device-Drug Regulations & Capabilities in the New Normal